A Comparative Study of the Effects of Osaterone Acetate and Deslorelin Acetate on Sperm Kinematics and Morpho-Functional Parameters in Dogs
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Animals and Study Groups
2.1.1. Group I (Negative Control—Healthy Stud Dogs)
2.1.2. Group II (Positive Control)
2.1.3. Group III (Deslorelin Acetate—SUPRELORIN® VIRBAC®)
2.1.4. Group IV (Osaterone Acetate—YPOZANE® VIRBAC®)
2.2. Study Design
2.2.1. Drug Administration
Group III
Group IV
2.3. Semen Analysis
2.3.1. Assessment of II Fraction
2.3.2. Evaluation of the III Semen Fraction
2.4. Statistical Analysis
3. Results
3.1. Evaluation of II Semen Fraction
3.2. Evaluation of III Semen Fraction
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Gobello, C.; Corrada, Y. Noninfectious prostatic disease in dogs. Compend. Contin. Educ. Pract. Vet. 2002, 2, 99–107. [Google Scholar]
- Memon, M.A. Common causes of male dog infertility. Theriogenology 2007, 68, 322–328. [Google Scholar] [CrossRef] [PubMed]
- Smith, J. Canine prostatic disease: A review of anatomy, pathology, diagnosis, and treatment. Theriogenology 2008, 70, 375–383. [Google Scholar] [CrossRef] [PubMed]
- Carson, C., III; Rittmaster, R. The role of dihydrotestosterone in Bening Prostatic Hyperplasia. Urology 2003, 61, 2–7. [Google Scholar] [CrossRef]
- Timmes, B.G.; Hofkamp, L.E. Prostate development and growth in Bening prostatic hyperplasia. Differentiation 2011, 82, 173–183. [Google Scholar] [CrossRef]
- Basinger, R. Surgical management of prostatic disease. Compend. Contin. Educ. Pract. Vet. 1987, 29, 993–999. [Google Scholar]
- Angrimani, D.S.R.; Brito, M.M.; Rui, B.R.; Nichi, M.; Vannucchi, C.I. Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs. Sci. Rep. 2020, 10, 14834. [Google Scholar] [CrossRef]
- Albouy, M.; Sanquer, A.; Maynard, L.; Eun, H.M. Efficacies of osaterone and delmadinone in the treatment of benign prostatic hyperplasia in dogs. Vet. Rec. 2008, 163, 179–183. [Google Scholar] [CrossRef]
- Fontaine, E.; Fontbonne, A. Clinical Use of GnRH Agonists in Canine and Feline Species. Reprod. Domest. Anim. 2010, 46, 344–353. [Google Scholar] [CrossRef]
- Goericke-Pesch, S.; Wilhelm, E.; Ludwig, C.; Desmoulins, P.; Driancourt, M.; Hoffmann, B. Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog. Theriogenology 2010, 73, 920–926. [Google Scholar] [CrossRef]
- Trigg, T.E.; Wright, P.J.; Armour, A.F.; Williamson, P.E.; Junaidi, A.; Marin, G.B.; Doyle, A.G.; Walsh, J. Use of GnRH analogue implant to produce reversible, lpng-term suppression of reproductive function of male and female domestic dogs. J. Reprod. Fertil. Suppl. 2001, 57, 255–261. [Google Scholar] [PubMed]
- Junaidi, A.; Williamson, P.E.; Cummins, J.M.; Martin, G.B.; Blackberry, M.A.; Trigg, T.E. Use of a New drug delivery formulation of the gonadotropin-releasing hormone analogue deslorelin for reversible long-term cobtraception in male dogs. Reprod. Fertil. Dev. 2003, 15, 317–322. [Google Scholar] [CrossRef] [PubMed]
- Trigg, T.E.; Doyle, A.G.; Walsh, J.D.; Swangchan-Uthai, T. A review of advances in the use of the GnRH agonist deslorelin in control of reproduction. Theriogenology 2006, 66, 1507–1512. [Google Scholar] [CrossRef] [PubMed]
- Junaidi, A.; Williamson, P.E.; Martin, G.B.; Blackberry, M.A.; Cummins, J.M.; Trigg, T.E. Dose-response studies for pituitary and testicular function in male dogs treated with the GnRH Superagonist, Deslorelin. Reprod. Domest. Anim. 2009, 44, 725–734. [Google Scholar] [CrossRef] [PubMed]
- Juanidi, A.; Williamson, P.E.; Trigg, T.E.; Cummins, J.M.; Martin, G.B. Morphological study of the effects of the GnRH superagonist deslorelin n the canine testis and prostate gland. Reprod. Domest. Anim. 2009, 44, 757–763. [Google Scholar] [CrossRef]
- Amann, R.P. Reproductive physiology and endocrinology of the dog. In Current Therapy in Theriogenology, 2nd ed.; Morrow, D.A., Ed.; Saunders Co.: Philadelphia, PA, USA, 1986; pp. 523–538. [Google Scholar]
- Niżański, W.; Dubiel, A.; Bielas, W.; Dejneka, G.J. Effect of three cryopreservation methods and two semen extenders of the quality of dog semen after tawing. J. Reprod. Fertil. 2001, 57, 365–369. [Google Scholar]
- Niżański, W. Intravaginal insemination of bitches with fresh and frozen-thawed semen with addition of prostatic fluid: Use of an infusion pipette and the Osiris catheter. Theriogenology 2006, 66, 470–483. [Google Scholar] [CrossRef]
- Szostak, B.; Buryś, Ł. Effect of breed and age on the morphology of A.I. boars spermatozoa. Ann. UMCS Zootech. 2011, 29, 44–51. [Google Scholar] [CrossRef]
- Johnston, S.D.; Root Kustritz, M.V.; Olson, P.N.S. Sexual differentiation and normal anatomy of the dog. In Canine and Feline Theriogenology; Johnston, S.D., Root Kustritz, M.V., Olson, P.N.S., Eds.; Saunders Co.: Philadelphia, PA, USA, 2001; pp. 275–285. [Google Scholar]
- Aczel, A.D. Statystyka w Zarządzaniu; Wyd. PWN: Warszawa, Poland, 2011. [Google Scholar]
- Polisca, A.; Orlandi, R.; Troisi, A.; Brecchia, G.; Zerani, M.; Boiti, C.; Zelli, R. Clinical efficacy of the GnRH agonist (Deslorelin) in dogs affected by Benin prostatic hyperplasia and evaluation of prostatic blood flow by Doppler ultrasound. Reprod. Domest. Anim. 2013, 48, 673–680. [Google Scholar] [CrossRef]
- Pyan-Carreira, R.; Miranda, S.; Niżański, W. Artifical insemination in dogs. In Artifical Insemination in Farm Animals; Manafi, M., Ed.; InTech: London, UK, 2011; rodz. 4; pp. 51–73. [Google Scholar]
- Linde-Forsberg, C. Achieving Canine Pregnancy by Using Frozen or Chilled Extended Semen. Vet. Clin. N. Am. Small Anim. Pract. 1991, 21, 467–485. [Google Scholar] [CrossRef]
- Romagnoli, S.; Siminica, A.; Sontas, B.H.; Milan, C.; Mollo, A.; Stelletta, C. Semen quality and onset of sterility following administration of a 4,7-mg deslorelin implant in adult male dog. Reprod. Domest. Anim. 2012, 47, 389–392. [Google Scholar] [CrossRef] [PubMed]
- Goericke-Pesch, S. Long-term effects of GnRH agonists on fertility and behaviour. Reprod. Domest. Anim. 2016, 52, 336–347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tsutsui, T.; Hori, T.; Shimizu, M.; Orima, H.; Kawakami, E.; Fukuda, S. Regression of Prostatic Hypertrophy by Osaterone Acetate in Dogs. J. Vet. Med. Sci. 2000, 62, 1115–1119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Murakoshi, M.; Inada, R.; Tagawa, M.; Makino, M.; Suzuki, M.; Mieda, M.; Honma, S.; Takezawa, Y.; Yamanaka, H. Inhibitory influence of a New steroid al antiandrogen, TZP-4238, on prostatic hyperplasia in the beagle dog. Acta Pathol. Jpn. 1992, 42, 151–157. [Google Scholar] [PubMed]
II Fraction Volume (mL) | Concentration (×106/mL) | Total Sperm Count (×106) | Motility (%) | Progressive Motility (%) | Defects (%) | Live Sperm (%) | |
---|---|---|---|---|---|---|---|
D0 n = 5 | 2.1 ± 0.5 | 220.8 ± 163.8 | 432.2 ± 268.3 | 96.8 ± 2.2 | 70.4 ± 10.2 | 9.2 ± 3.6 | 95.3 ± 4.8 |
D7 n = 5 | 1.9 ± 0.1 | 217.4 ± 154.1 | 410.3 ± 327.8 | 97.0 ± 2.9 | 75.0 ± 3.2 | 7.6 ± 4.2 | 97.0 ± 1.1 |
D14 n = 5 | 2.1 ± 1.0 | 266.8 ± 174.3 | 590.8 ± 549.1 | 95.6 ± 3.3 | 57.0 ± 31.3 | 10.2 ± 7.2 | 97.3 ± 2.3 |
D21 n = 5 | 2.0 ± 0.7 | 293.5 ± 194.5 | 507.6 ± 179.0 | 90.0 ± 1.3 | 73.7 ± 5.2 | 10.1 ± 3.1 | 98.1 ± 1.1 |
W + 8 n = 5 | 1.7 ± 0.5 | 285.3 ± 303.8 | 397.0 ± 400.8 | 93.5 ± 8.4 | 58.7 ± 24.3 | 11.7 ± 4.3 | 98.5 ± 0.6 |
W + 12 n=5 | 2.1 ± 1.0 | 229.2 ± 133.1 | 412.8 ± 243.1 | 94.5 ± 5.8 | 66.5 ± 6.5 | 7.5 ± 2.7 | 98.0 ± 1.4 |
W + 16 n = 5 | 1.6 ± 0.8 | 452.0 ± 291.4 | 613.9 ± 420.4 | 97.5 ± 1.3 | 73.8 ± 7.8 | 7.5 ± 1.1 | 96.3 ± 2.1 |
W + 20 n = 5 | 1.2 ± 1.0 | 275.1 ± 183.0 | 387.7 ± 485.5 | 96.5 ± 3.1 | 57.3 ± 18.2 | 8.5 ± 3.1 | 98.6 ± 0.3 |
VAP | VSL | VCL | ALH | BCF | STR | LIN | RAPID | STATIC | |
---|---|---|---|---|---|---|---|---|---|
D0 n = 5 | 146.4 ± 21.1 | 138.6 ± 31.6 | 187.2 ± 38.9 | 5.7 ± 1.3 | 33.3 ± 5.0 | 92 ± 2.8 | 73 ± 6.3 | 77.4 ± 13.5 | 3.2 ± 2.2 |
D7 n = 5 | 170.9 ± 9.5 | 155.0 ± 3.5 | 226.6 ± 30.8 | 6.9 ± 1.1 | 34.3 ± 4.2 | 90.3 ± 4.5 | 70 ± 8.9 | 85 ± 7.6 | 2.65 ± 2.5 |
D14 n = 5 | 147.4 ± 45.3 | 149.9 ± 7.7 | 193.7 ± 5 | 6.2 ± 1.2 | 29.8 ± 4.6 | 85 ± 12.1 | 66 ± 16.3 | 66 ± 35.5 | 4.4 ± 3.3 |
D21 n = 5 | 158.0 ± 14.0 | 142.2 ± 10.7 | 206.5 ± 3 | 6.2 ± 1.1 | 34.0 ± 2.6 | 89 ± 3.2 | 67 ± 5.4 | 84.83 ± 5.0 | 2 ± 1.3 |
W + 8 n = 5 | 141.8 ± 31.3 | 130.0 ± 28.7 | 188.3 ± 27.1 | 6.2 ± 1.5 | 33.6 ± 6.0 | 91 ± 3.8 | 68 ± 10.9 | 66.17 ± 7.4 | 6.5 ± 8.4 |
W + 12 n = 5 | 148.1 ± 19.1 | 133.7 ± 11.4 | 195.7 ± 33.8 | 6.3 ± 1.4 | 31.3 ± 7.9 | 90 ± 5.4 | 69 ± 7.8 | 75.5 ± 9.88 | 5.5 ± 5.8 |
W + 16 n = 5 | 169.9 ± 14.3 | 153.1 ± 14.3 | 216.7 ± 19.6 | 6.2 ± 0.9 | 31.5 ± 4.0 | 89 ± 4.9 | 71 ± 7.0 | 85.3 ± 2.6 | 2.5 ± 1.3 |
W + 20 n = 5 | 138.6 ± 31.6 | 123.7 ± 34.1 | 191.6 ± 3 | 7.7 ± 1.6 | 29.2 ± 5.0 | 87.3 ± 5.6 | 64.3 ± 8.8 | 64.8 ± 17.7 | 3.5 ± 3.1 |
II Fraction Volume (mL) | Concentration (×106/mL) | Total sperm Count (×106) | Motility (%) | Progressive Motility (%) | Defects (%) | Live Sperm (%) | |
---|---|---|---|---|---|---|---|
D0 n = 11 | 2.2 ± 1.2 | 167.6 ± 148.8 | 433.2 ± 532.3 | 87.6 ± 8.2 | 61.6 ± 18.6 | 19.9 ± 10.1 | 94.6 ± 3.9 |
D7 n = 10 | 2.6 ± 1.5 | 215.2 ± 163.8 | 534.4 ± 401.2 | 82.6 ± 21.4 | 53.8 ± 25.1 | 19.1 ± 5.6 | 91.5 ± 5.1 |
D14 n = 9 | 2.5 ± 1.7 | 204.7 ± 155.6 | 406.3 ± 282.8 | 72.6 ± 34.4 | 50.7 ± 27.5 | 29.3 ± 8.2 | 91.1 ± 3.7 |
D21 n = 2 | 2.4 ± 1.0 | 172.4 ± 119.9 | 392.8 ± 331.9 | 89.4 ± 10.0 | 63.6 ± 19.6 | 24.1 ± 10.9 | 91.6 ± 5.1 |
W + 8 n = 2 | 2.9 ± 1.6 | 97.3 ± 128.6 | 182.2 ± 221.5 | 65 ± 38.2 | 35.5 ± 23.3 | 48.5 A ± 6.4 | 86.5 ± 8.5 |
VAP | VSL | VCL | ALH | BCF | STR | LIN | RAPID | STATIC | |
---|---|---|---|---|---|---|---|---|---|
D0 n = 11 | 150.5 ± 22.6 | 139.9 ± 22.4 | 196.0 ± 31.8 | 6.5 ± 1.6 | 31.0 ± 5.0 | 92 ± 4.3 | 72 ± 10.0 | 663 ± 20.5 | 12.36 ± 8.19 |
D7 n = 10 | 145.8 ± 36.2 | 130.5 ± 32.8 | 196.2 ± 45.4 | 6.9 ± 2.0 | 29.9 ± 4.3 | 89 ± 6.0 | 67 ± 11.6 | 61.8 ± 27.2 | 17.4 ± 21.14 |
D14 n = 9 | 141.3 ± 31.4 | 128.3 ± 28.8 | 197.5 ± 41.0 | 6.43 ± 2.2 | 31.3 ± 5.7 | 90 ± 3.6 | 67 ± 11.8 | 56.1 ± 31.1 | 27.43 ± 34.41 |
D21 n = 2 | 155.9 ± 21.4 | 143.8 ± 24.0 | 207.5 ± 19.2 | 6.7 ± 1.8 | 31.2 ± 4.0 | 91 ± 3.9 | 70 ± 12.1 | 69.2 ± 21.0 | 10.56 ± 10.03 |
W + 8 n = 2 | 129.2 ± 10.3 | 117 ± 22.8 | 187.3 ± 43.6 | 6.4 ± 3.0 | 28.3 ± 1.7 | 89 ± 9.9 | 66 ± 24.8 | 42.5 ± 33.2 | 35.0 ± 38.2 |
II Fraction Volume (mL) | Concentration (×106/mL) | Total Sperm Count (×106) | Motility (%) | Progressive Motility (%) | Defects (%) | Live Sperm (%) | |
---|---|---|---|---|---|---|---|
D0 n = 6 | 2.5 ± 0.8 | 287.4 ± 178.9 | 678.6 ± 384.9 | 90.3 ± 7.9 | 50.7 ± 23.7 | 35.7 ± 24.5 | 95.6 ± 2.9 |
D7 n = 6 | 1.7 ± 0.5 | 238.2 ± 272.5 | 269.9 ± 215.2 | 87.3 ± 8.02 | 39.3 ± 20.1 | 41.3 ± 23.1 | 94.0 ± 0.7 |
D14 n = 6 | 1.6 ± 1.0 | 385.4 ± 187.0 | 623.4 ± 363.0 | 83 ± 13.2 | 38.6 ± 26.0 | 32.3 ± 23.9 | 93.0 ± 3.6 |
D21 n = 6 | 1.4 ± 0.9 | 739.0 A ± 558.0 | 772.6 ± 569.9 | 68.6 A ± 20.9 | 21.6 A ± 16.4 | 31.9 ± 19.5 | 94.3 ± 0.9 |
T + 8 n = 6 | 1.0 B ± 0.6 | 520.2 A ± 181.7 | 501.6 ± 377.5 | 84.8 ± 7.8 | 37.7 ± 20.7 | 37.2 ± 18.1 | 93.9 ± 4.2 |
W + 12 n = 6 | 1.6 ± 0.4 | 350.8 ± 88.7 | 524.0 ± 35.3 | 84.3 ± 13.2 | 44.5 ± 17.7 | 27.8 ± 12.8 | 93.3 ± 3.8 |
VAP | VSL | VCL | ALH | BCF | STR | LIN | RAPID | STATIC | |
---|---|---|---|---|---|---|---|---|---|
D0 n = 6 | 124.7 ± 32.0 | 115.0 ± 28.7 | 159.6 ± 48.2 | 6.0 ± 0.7 | 43.1 ± 36.5 | 94 ± 10.7 | 76 ± 20.1 | 56.2 ± 26.7 | 9.7 ± 7.9 |
D7 n = 6 | 99.1 ± 32.4 | 87.7 ± 33.3 | 130.8 ± 25.7 | 5.68 ± 0.6 | 25.4 ± 9.3 | 85 ± 11.2 | 64 ± 16.2 | 46.3 ± 15.9 | 11.3 ± 7.0 |
D14 n = 6 | 107.0 ± 52.3 | 95.6 ± 48.2 | 152.2 ± 68.2 | 6.1 ± 1.2 | 30.6 ± 5.2 | 87.4 ± 3.6 | 62 ± 9.2 | 42.8 ± 23.0 | 25.3 ± 18.2 |
D21 n = 6 | 101.9 ± 21.9 | 87.6 ± 25.9 | 154.7 ± 22.3 | 6.9 ± 2.0 | 25.7 ± 5.9 | 84 ± 8.5 | 57 ± 16.3 | 26.0 ± 16.2 | 31.4 A ± 20.9 |
W + 8 n = 6 | 112.9 ± 14.8 | 98.8 ± 17.3 | 172.1 ± 37.1 | 6.5 ± 1.6 | 30.1 ± 5.7 | 86 ± 7.9 | 59 ± 13.8 | 43.5 ± 21.5 | 15.2 ± 7.8 |
W + 12 n = 6 | 121.6 ± 17.7 | 112.5 ± 17.0 | 165.7 ± 21.5 | 5.9 ± 1.1 | 33.2 ± 3.7 | 91 ± 1.0 | 69 ± 4.8 | 52.3 ± 12.3 | 9.3 ± 7.9 |
W + 16 n = 6 | 129.6 ± 20.1 | 113.9 ± 17.8 | 181.8 ± 38.4 | 6.2 ± 1.7 | 31.4 ± 3.2 | 86 ± 4.0 | 63 ± 11.0 | 60.7 ± 23.0 | 6.0 ± 3.6 |
W + 20 n = 6 | 111.5 ± 35.1 | 98.6 ± 35.2 | 160.7 ± 20.9 | 6.4 ± 2.2 | 30.4 ± 0.9 | 86 ± 7.1 | 61 ± 16.4 | 41.6 ± 32.0 | 22.4 ± 19.6 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Niżański, W.; Eberhardt, M.; Ochota, M.; Fontaine, C.; Levy, X.; Pasikowska, J. A Comparative Study of the Effects of Osaterone Acetate and Deslorelin Acetate on Sperm Kinematics and Morpho-Functional Parameters in Dogs. Animals 2022, 12, 1548. https://doi.org/10.3390/ani12121548
Niżański W, Eberhardt M, Ochota M, Fontaine C, Levy X, Pasikowska J. A Comparative Study of the Effects of Osaterone Acetate and Deslorelin Acetate on Sperm Kinematics and Morpho-Functional Parameters in Dogs. Animals. 2022; 12(12):1548. https://doi.org/10.3390/ani12121548
Chicago/Turabian StyleNiżański, Wojciech, Maria Eberhardt, Małgorzata Ochota, Christelle Fontaine, Xavier Levy, and Joanna Pasikowska. 2022. "A Comparative Study of the Effects of Osaterone Acetate and Deslorelin Acetate on Sperm Kinematics and Morpho-Functional Parameters in Dogs" Animals 12, no. 12: 1548. https://doi.org/10.3390/ani12121548